Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenuit Group Regulatory News (GEN)

Share Price Information for Genuit Group (GEN)

Share Price is delayed by 15 minutes
Get Live Data
254.00    2.00 (0.79%)
Bid:
254.00
Ask:
255.40
Spread: 1.40 (0.551%)
Market Cap: £640.05m
GEN Live PriceLast checked at - London Stock Exchange

Intraday Genuit Group Share Chart

Board updates

8 Mar 2023 16:26

RNS Number : 3439S
Genuit Group PLC
08 March 2023
 

8 March 2023

 

Genuit Group plc

 

Board updates

 

In accordance with FCA Listing Rule 9.6.11, Genuit Group plc (the 'Company') announces that Mark Hammond, Non-Executive Director, Senior Independent Director ('SID') and member of the Audit, Nomination and Remuneration Committees, has today stepped down from his role as SID but has agreed to remain on the Board beyond the completion of his nine-year term in April 2023. Given Mr Hammond's extensive experience of the Group, the need to onboard two new Non-Executive Directors and the requirement for an orderly handover, the Board is of the view that an extension to Mr Hammond's term is in the best interests of the Company. Having assessed Mr Hammond's independence, the Board has confirmed that in their view, he remains an independent Non-Executive Director of the Board and that his nine-year tenure does not impair his ability to challenge independently. The expectation is that Mr Hammond will retire from the Board in October 2023.

 

Lisa Scenna will take over as SID with effect from 8 March 2023. Ms Scenna has been a Non-Executive Director of the Company since September 2019 and is the Chair of the Remuneration Committee and a member of the Audit and Nomination Committees.

 

 

For further information please contact:

 

 

 

Emma Versluys +44 (0)1138 315315

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAJPMFTMTTMBIJ
Date   Source Headline
4th Jun 20263:05 pmRNSHolding(s) in Company
2nd Jun 20261:15 pmRNSDirector/PDMR Shareholding
29th May 20262:39 pmRNSTotal Voting Rights
29th May 20262:23 pmRNSHolding(s) in Company
29th May 20261:59 pmRNSDirector/PDMR Shareholding
28th May 20262:24 pmRNSHolding(s) in Company
27th May 202610:07 amRNSDirector/PDMR Shareholding
26th May 20263:49 pmRNSHolding(s) in Company
22nd May 20263:01 pmRNSResult of AGM
22nd May 20267:00 amRNSTrading Update
5th May 20269:00 amRNSDirector/PDMR Shareholding
1st May 20264:12 pmRNSDirector/PDMR Shareholding
30th Apr 20264:26 pmRNSAdmission to Trading
30th Apr 20264:17 pmRNSTotal Voting Rights
30th Apr 20264:06 pmRNSDirector/PDMR Shareholding
27th Apr 20264:20 pmRNSHolding(s) in Company
14th Apr 20264:32 pmRNSDirector/PDMR Shareholding
14th Apr 202610:11 amRNSNotice of AGM
10th Apr 20261:34 pmRNSBlock Listing Application
7th Apr 20269:58 amRNSHolding(s) in Company
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20266:01 pmRNSTotal Voting Rights
23rd Mar 20263:25 pmRNSHolding(s) in Company
20th Mar 20261:43 pmRNSDirector/PDMR Shareholding
13th Mar 20269:41 amRNSHolding(s) in Company
13th Mar 20269:41 amRNSHolding(s) in Company
11th Mar 20262:12 pmRNSFull-Year 2025 Results Investor Q&A
10th Mar 20267:00 amRNSFinal Results
6th Mar 202611:35 amRNSHolding(s) in Company
5th Mar 20262:46 pmRNSHolding(s) in Company
5th Mar 20262:41 pmRNSHolding(s) in Company
4th Mar 20262:40 pmRNSHolding(s) in Company
3rd Mar 20263:51 pmRNSHolding(s) in Company
2nd Mar 20265:25 pmRNSHolding(s) in Company
27th Feb 20263:18 pmRNSTotal Voting Rights
30th Jan 20266:00 pmRNSTotal Voting Rights
29th Jan 202610:17 amRNSHolding(s) in Company
29th Jan 202610:15 amRNSHolding(s) in Company
29th Jan 202610:06 amRNSHolding(s) in Company
12th Jan 20265:41 pmRNSHolding(s) in Company
31st Dec 202510:00 amRNSTotal Voting Rights
31st Dec 202510:00 amRNSTotal Voting Rights
23rd Dec 20259:08 amRNSHolding(s) in Company
23rd Dec 20259:08 amRNSHolding(s) in Company
23rd Dec 20259:06 amRNSHolding(s) in Company
23rd Dec 20259:06 amRNSHolding(s) in Company
16th Dec 20252:03 pmRNSHolding(s) in Company
16th Dec 20252:01 pmRNSHolding(s) in Company
12th Dec 20253:41 pmRNSDirector/PDMR Shareholding
10th Dec 20254:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.